Skip to contentN
National Health Investors Inc
N
NHINational Health Investors Inc Q1 2025 · 10-Q
Revenue$13.94M$13.94M+5.2% vs Q1 2024 Net Income$34.17M$34.17M+10.4% vs Q1 2024 EPS Diluted$0.74$0.74+4.2% vs Q1 2024 Operating Cash Flow$46,478,000+13.8% Free Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR
derived
ended Mar 31, 2025 · filed May 5, 2025 · 35 d after period end